Riskpilot← Back to searchSign inGet full accessALLERGICA A/S
A/SActiveCVR 11919677Hagemannsvej 11Manufacture of pharmaceutical preparations · NACE 2120Est. 198822 employees
Revenue 2025
DKK 15,2M
+1% vs 2024
EBITDA margin
4.2%
-5% vs 2024
Equity ratio
52.8%
Financial strength
Net profit 2025
DKK 299K
-19% vs 2024
| Revenue | DKK 15,2M | +1% |
| EBITDA | DKK 635K | -5% |
| Net profit | DKK 299K | -19% |
| Total assets | DKK 19,5M | -1% |
| Equity | DKK 10,3M | +2% |
| Employees | 22 | — |
Legal name
ALLERGICA A/S
CVR number
11919677
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
29. januar 1988
Share capital
DKK 560.000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden eller direktøren i forening med to bestyrelsesmedlemmer, eller af den samlede bestyrelse
Company purpose
Selskabets formål er at udvikle, producere og forhandle antroposofisk og homøopatisk medicin samt andre helsebringende produkter.Det er herudover selskabets formål at støtte antroposofisk virksomhed - herunder specielt antroposofisk medicinsk forskning og oplysningsvirksomhed i Danmark. Selskabets overordnede ideer bygger på antroposofi, som fremlagt af Rudolf Steiner. Det betyder, at selskabet fokuserer på produkter og præparater, som styrker det enkelte menneskes legemlige og sjælelige tilstand, og som derudover aktiverer menneskets egen evne til selvhelbredelse. Det tilstræbes, at selskabets produktion og øvrige virke foregår med mindst mulig miljøbelastning og med stor hensyntagen til de involverede mennesker. Selskabet vil ydermere støtte medarbejderne i deres udvikling, både på det faglige og det samarbejdsmæssige plan. Selskabets formål kan fremmes på enhver måde bestyrelsen finder hensigtsmæssig, herunder skal selskabet også være berettiget til at fremme sit formål gennem fondsstiftelse, således at formålet også langsigtet kan tilgodeses via aktiviteterne i en sådan fond.
Address
Hagemannsvej 11
Phone
+4570261777
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.953 | 11.734 | 11.835 | 11.946 | 12.797 | 13.708 | 14.801 | 16.354 | 15.519 | 15.280 | 15.138 | 15.231 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 1.252 | 2.199 | 1.653 | 1.293 | 1.094 | 789 | 965 | 2.552 | 374 | 666 | 666 | 635 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1.252 | 2.199 | 1.653 | 1.293 | 1.094 | 789 | 965 | 2.552 | 374 | 666 | 666 | 635 |
| Net financials | -179 | -159 | -130 | -152 | -182 | -116 | -173 | -190 | -266 | -221 | -240 | -265 |
| Profit before tax | 1.072 | 2.040 | 1.523 | 1.141 | 912 | 673 | 792 | 2.363 | 107 | 444 | 427 | 370 |
| Tax | 264 | 478 | 397 | 254 | 204 | 145 | 180 | 434 | -4 | 95 | 59 | 71 |
| Net profit | 808 | 1.562 | 1.126 | 887 | 709 | 528 | 612 | 1.929 | 111 | 349 | 368 | 299 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7.613 | 9.420 | 9.823 | 14.350 | 13.649 | 13.753 | 15.631 | 20.635 | 17.644 | 18.097 | 19.694 | 19.470 |
| Equity | 2.696 | 4.257 | 5.383 | 6.270 | 6.979 | 7.107 | 7.719 | 9.448 | 9.359 | 9.709 | 10.076 | 10.275 |
| Long-term debt | 2.753 | 2.629 | 1.100 | 2.842 | 2.604 | 2.356 | 2.703 | 4.701 | 4.520 | 4.346 | 4.698 | 4.546 |
| Short-term debt | 1.941 | 2.232 | 3.004 | 4.733 | 3.409 | 3.523 | 4.343 | 5.444 | 2.725 | 2.908 | 3.727 | 3.385 |
| Total debt | 4.694 | 4.862 | 4.104 | 7.575 | 6.013 | 5.879 | 7.046 | 10.145 | 7.245 | 7.254 | 8.425 | 7.931 |
EBITDA margin
4.2%
This company
15.8%
Market median
-73% vs market
20142025
Equity ratio
52.8%
This company
38.2%
Market median
+38% vs market
20142025
Return on equity
2.9%
This company
18.4%
Market median
-84% vs market
20142025
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
20142025
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20142025
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JC Chief Executive Officer | Chief Executive Officer | 2011 | — | — |
KK Management | Management | 2004 | — | — |
JH Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
AE Management | Management | 2008 | — | — |
KK Audit | Audit | 2003 | — | — |
LW Management | Management | 2008 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2002 | — | — | |
| Chairman | 1988 | — | — | |
| Board of Directors | 1988 | — | — | |
| Deputy Chairman | 2002 | — | — | |
| Board of Directors | 2004 | — | — | |
| Deputy Chairman | 2014 | — | — | |
| Chairman | 1988 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2013 | — | — | |
| Deputy Chairman | 2026 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 1988 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Chairman | 2008 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Æskulapfonden | Company | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Æskulapfonden
ALLERGICA A/S Board members of ALLERGICA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Christian Schrøder | Chief Executive Officer | 0 companies |
| Klaus Kristian Sall | Management | 0 companies |
| Jan Hein Nielsen | Chief Executive Officer | 0 companies |
| Anneke Estcourt Stubsgaard | Management | 0 companies |
| Klaus Kristiansen | Audit | 0 companies |
| Lise Wende Møller | Management | 0 companies |
| Randi Brøndegaard Nielsen | Board of Directors | 0 companies |
| Joan Bøgh Christensen | Board of Directors | 0 companies |
| Bodil Højbjerg Hea | Board of Directors | 0 companies |
| Tina Lauritsen | Board of Directors | 0 companies |
| Karl Kristian Gillhøj | Board of Directors | 0 companies |
| Arne Hallingdal | Board of Directors | 0 companies |
| Claudia Maria Weise | Board of Directors | 0 companies |
| Ole Kalyana Kjær Johansen | Board of Directors | 0 companies |
| Kirsten Irene Kjeldsen | Board of Directors | 0 companies |
| Else Marie Pedersen | Board of Directors | 0 companies |
| Thomas Borgaa | Board of Directors | 0 companies |
| Louise Dahl Krath Jensen | Chairman | 0 companies |
| Nevena Tijanic Hvarregaard | Board of Directors | 0 companies |
| Angelika Solveig Karup Marning | Board of Directors | 0 companies |
| Tine Schmidt | Board of Directors | 0 companies |
| Sibylla Maria Hofstetter | Board of Directors | 0 companies |
| Lotte Lauesen | Board of Directors | 0 companies |
| Lars Pehrson | Board of Directors | 0 companies |
| Finn Nørlev | Board of Directors | 0 companies |
| Dorte Madsen | Chairman | 0 companies |
| Niels Erik Bach Boesen | Board of Directors | 0 companies |
| Knud Thorbjørn Hansen | Deputy Chairman | 0 companies |
| Peer Matthias Heissel | Board of Directors | 0 companies |
| Peer Bach Boesen | Deputy Chairman | 0 companies |
| Karsten Græsbøll Munk | Chairman | 0 companies |
| Finn Madsen | Board of Directors | 0 companies |
| Ulf Monrad Gaardsted | Board of Directors | 0 companies |
| Bent Engelbrecht | Board of Directors | 0 companies |
| Qristel Mette Viben Nielsen | Board of Directors | 0 companies |
| Birthe Storgaard | Board of Directors | 0 companies |
| Ann-Louise Sørensen | Board of Directors | 0 companies |
| Jesper Hollensberg | Deputy Chairman | 0 companies |
| Helle Kofoed | Board of Directors | 0 companies |
| Sven Ole Schmidt | Board of Directors | 0 companies |
| Hans Thomas Hald | Board of Directors | 0 companies |
| Charlotte Sambuc Christensen | Board of Directors | 0 companies |
| Monica Nissen | Deputy Chairman | 0 companies |